Transcranial Magnetic Stimulation for Modulating Muscle Response in Humans
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 4:05 min • August 29th, 2025
Loading...
Overview
This study investigates the effects of transcranial magnetic stimulation (TMS) on the excitability of cortical neurons and muscle activation. By utilizing EMG to measure muscle response, the research aims to understand the relationship between cortical stimulation and motor control.
Key Study Components
Area of Science
- Neuroscience
- Electrophysiology
- Motor Control
Background
- Transcranial magnetic stimulation (TMS) is a non-invasive method to stimulate cortical neurons.
- Electromyography (EMG) measures muscle response to cortical activation.
- Understanding cortical excitability can enhance knowledge of motor control mechanisms.
- GABAergic interneurons play a crucial role in modulating motor neuron activity.
Purpose of Study
- To identify the optimal TMS parameters for eliciting muscle contraction.
- To explore the relationship between TMS intensity and muscle activation.
- To assess the effects of subthreshold TMS on EMG suppression.
Methods Used
- Participants fitted with EMG electrodes on the FDI muscle.
- Reflective markers placed for TMS coil stabilization.
- Mapping procedure to find the hot spot for TMS application.
- Recording EMG signals during isometric finger abductions with varying TMS intensities.
Main Results
- Identified the optimal coil position for maximal muscle contraction.
- Demonstrated that reduced TMS intensity can suppress EMG activity.
- Found a significant difference in muscle activation with and without TMS.
- Established a clear relationship between TMS intensity and motor neuron excitability.
Conclusions
- TMS can effectively modulate cortical excitability and muscle control.
- Subthreshold TMS provides insights into GABAergic inhibition mechanisms.
- Findings contribute to understanding motor control and potential therapeutic applications.
Frequently Asked Questions
What is TMS?
Transcranial magnetic stimulation (TMS) is a non-invasive technique used to stimulate specific areas of the brain.
How does EMG work?
Electromyography (EMG) measures the electrical activity of muscles during contraction.
What is the purpose of finding the hot spot?
The hot spot is the optimal position for TMS application to elicit the strongest muscle response.
What role do GABAergic interneurons play?
GABAergic interneurons inhibit pyramidal neurons, helping to regulate muscle activation and control.
What were the main findings of the study?
The study found that TMS can modulate muscle activation and that subthreshold stimulation can suppress EMG activity.
Executive Industry Relevance
Transcranial magnetic stimulation (TMS) enables non-invasive modulation of cortical excitability to probe motor neuron pathways and assess inhibitory control mechanisms. This approach supports target validation in neuromuscular discovery by quantifying subthreshold effects on muscle response via electromyography (EMG). The method provides predictive confidence in early-stage screening of compounds or interventions influencing cortical GABAergic transmission.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by measuring EMG suppression as a readout of intracortical inhibition.
- Operational Value: Enables functional validation of cortical targets through dose-response mapping of TMS intensity to muscle activation.
- Predictive Value: Supports portfolio triage by quantifying GABAergic-mediated neuromodulation relevant to motor disorder indications.
Screening & Assay Development
- Assay Readiness: Prepares validated neuromuscular systems for downstream screening by establishing reliable hotspot localization and stimulation thresholds.
- Quantitative Output: Generates EMG suppression metrics that enable standardized, reproducible assessment of compound effects on cortical inhibition.
- Scalability: Supports platform reuse across studies through counterbalanced trial designs and inter-stimulus interval randomization.
Translational & Preclinical Research
- Translational Continuity: Bridges discovery to preclinical validation by aligning EMG suppression readouts with disease-relevant motor control biomarkers.
- Mechanistic De-risking: Clarifies pathway engagement by isolating GABAergic interneuron effects on pyramidal neuron excitability.
- Risk-Adjusted Decisions: Informs advancement criteria through statistically defined EMG suppression onset windows (20–50 ms post-stimulus).
Pipeline & Workflow Integration
The method integrates into early discovery workflows by enabling hypothesis testing of cortical targets, progressing to assay development for screening applications, and supporting translational continuity through biomarker-aligned neuromuscular readouts.
- Discovery Biology: Supports pathway clarification and biological de-risking by measuring EMG suppression as a proxy for intracortical inhibition.
- Screening: Delivers assay readiness via standardized hotspot mapping and active motor threshold determination for consistent stimulation dosing.
- Analytics: Provides quantitative EMG measurements in defined time windows to enable cross-condition comparison and effect size calculation.
- Translational Research: Connects to preclinical work through force-matched isometric contractions and suppression onset thresholds relevant to motor circuit integrity.
- Enterprise Reuse: Establishes a reusable neuromuscular profiling capability via counterbalanced trial protocols and neuro-navigation stabilized coil positioning.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through quantifiable EMG suppression reflecting GABAergic modulation.
- Operational Value: Standardization and reproducibility via counterbalanced trial designs and fixed inter-stimulus intervals.
- Strategic Value: Improved go/no-go decisions by reducing mechanistic ambiguity in cortical target engagement.
- Portfolio Impact: Risk-adjusted prioritization based on dose-dependent suppression of muscle response at subthreshold intensities.
Implementation Considerations
- Requires expertise in neurophysiology, TMS safety protocols, and EMG signal processing.
- Depends on figure-of-eight coil compatibility with neuro-navigation systems for coil stabilization.
- Necessitates cross-team standardization of force-matching protocols and inter-stimulus interval randomization.
- Involves adaptation considerations for varying muscle groups and participant motor baseline variability.
- Limited by the need for individualized threshold determination (AMT) and suppression onset calibration per subject.
Biopharma FAQs
Why does EMG suppression matter for target validation?
EMG suppression serves as a quantitative readout of intracortical inhibition, enabling assessment of GABAergic interneuron engagement following subthreshold TMS. This measurement supports target validation by linking cortical stimulation intensity to functional motor output changes.
How does isolating the active motor threshold fit the discovery pipeline?
Determining the active motor threshold establishes a standardized stimulation intensity baseline for dose-response testing across experimental conditions. This isolation enables reproducible comparison of subthreshold effects on muscle response in early discovery workflows.
What do quantitative EMG measurements enable in screening?
Quantitative EMG measurements in the 20–50 ms post-stimulus window allow detection of suppression onset and magnitude, providing a scalable readout for compound screening. These measurements support assay standardization by defining clear temporal windows for effect detection.
Why do replication requirements matter for cross-functional collaboration?
Performing 40 trials with and without TMS in counterbalanced order ensures statistical reliability of EMG suppression detection, reducing variability across operators and sites. This replication supports consistent data interpretation between discovery, assay development, and translational teams.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to compute trial-by-trial differences in EMG signals and identify sustained negative deflections lasting at least four milliseconds. This capability enables objective definition of suppression onset based on pre-established temporal criteria.
09:52
Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
Related Videos
0 Views
06:05
Employing Transcranial Magnetic Stimulation in a Resource Limited Environment to Establish Brain-Behavior Relationships
Related Videos
0 Views
08:24
Conventional and Threshold-Tracking Transcranial Magnetic Stimulation Tests for Single-handed Operation
Related Videos
0 Views
12:19
Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System
Related Videos
0 Views
06:02
Repetitive Transcranial Magnetic Stimulation-Induced Changes in Human Corticomotoneuronal Synapses
Related Videos
0 Views
03:49
Real-Time Electroencephalography-Triggered Transcranial Magnetic Stimulation for Cortical Excitation
Related Videos
0 Views
03:49
Non-Invasive Electrical Brain Stimulation for Modulating Human Motor Neuron Activity
Related Videos
0 Views
05:36
Assessing Corticospinal Pathways Using Transcranial Magnetic Stimulation
Related Videos
0 Views
13:56
The Use of Magnetic Resonance Spectroscopy as a Tool for the Measurement of Bi-hemispheric Transcranial Electric Stimulation Effects on Primary Motor Cortex Metabolism
Related Videos
0 Views
08:55
Online Transcranial Magnetic Stimulation Protocol for Measuring Cortical Physiology Associated with Response Inhibition
Related Videos
0 Views
Last updated: 1 August 2026